Hospital Clínic de Barcelona

Migration, Crosslink

📖

Hospital Clínic de Barcelona

active

wiki page Created: 2026-04-02T07:20:11 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-hospital-clinic-barcel

📖 Wiki Page

institution2178 wordssynced 2026-04-02

Introduction

flowchart TD institutions_hospital_clinic_b["Hospital Clnic de Barcelona"] style institutions_hospital_clinic_b fill:#4fc3f7,stroke:#333,color:#000 institutions_hospita_0["Institutional Overview"] institutions_hospital_clinic_b -->|"includes"| institutions_hospita_0 style institutions_hospita_0 fill:#81c784,stroke:#333,color:#000 institutions_hospita_1["Historical Development"] institutions_hospital_clinic_b -->|"includes"| institutions_hospita_1 style institutions_hospita_1 fill:#ef5350,stroke:#333,color:#000 institutions_hospita_2["Research Infrastructure"] institutions_hospital_clinic_b -->|"includes"| institutions_hospita_2 style institutions_hospita_2 fill:#ffd54f,stroke:#333,color:#000 institutions_hospita_3["Neurodegenerative Disease Programs"] institutions_hospital_clinic_b -->|"includes"| institutions_hospita_3 style institutions_hospita_3 fill:#ce93d8,stroke:#333,color:#000 institutions_hospita_4["Memory Unit and Dementia Clinic"] institutions_hospital_clinic_b -->|"includes"| institutions_hospita_4 style institutions_hospita_4 fill:#4fc3f7,stroke:#333,color:#000 institutions_hospita_5["Movement Disorders Program"] institutions_hospital_clinic_b -->|"includes"| institutions_hospita_5 style institutions_hospita_5 fill:#81c784,stroke:#333,color:#000

...

Introduction

Mermaid diagram (expand to render)

Hospital Clínic de Barcelona is one of Spain's leading university hospitals and a premier center for neurodegenerative disease research in the Mediterranean region. Founded in 1906 and affiliated with the University of Barcelona's Faculty of Medicine, the hospital serves as a major referral center for patients across Catalonia and the broader Spanish healthcare system. The institution is internationally recognized for its research in Alzheimer's disease, Parkinson's disease, Huntington's disease, and related neurodegenerative conditions.

The hospital's research programs span the full translational spectrum, from basic science investigations of disease mechanisms through clinical trials of novel therapeutic interventions. The combination of a large patient population, experienced clinical researchers, and state-of-the-art research facilities positions Hospital Clínic as a leading institution in the global effort to understand and combat neurodegenerative diseases.

The hospital's commitment to neurodegenerative disease research is reflected in its substantial investment in specialized units, including the Memory Unit and Dementia Clinic, the Movement Disorders Program, and dedicated research laboratories focusing on biomarker development, neuroimmunology, and therapeutic discovery.

Institutional Overview

Historical Development

Hospital Clínic de Barcelona was founded in 1906 as a teaching hospital affiliated with the University of Barcelona's Faculty of Medicine. Over more than a century of operation, the institution has grown from a modest regional hospital into one of Spain's leading academic medical centers, with particular strength in neuroscience and neurodegenerative disease research.

The modern era of neurodegenerative disease research at Hospital Clínic began in the late 1990s, with the establishment of dedicated memory and movement disorders programs. These programs were designed to bring together clinicians and researchers from multiple disciplines to tackle the complex challenges posed by Alzheimer's disease, Parkinson's disease, and related disorders.

The hospital's affiliation with the University of Barcelona provides access to a large pool of talented researchers and students, while the partnership with IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer) enables translation of basic science discoveries into clinical applications.

Research Infrastructure

Hospital Clínic de Barcelona houses state-of-the-art research facilities that support comprehensive investigation of neurodegenerative diseases:

IDIBAPS Research Institute: The affiliated research institute provides core facilities for genomics, proteomics, cell biology, and animal models
Clinical Research Unit: Dedicated infrastructure for conducting clinical trials from Phase I through Phase IV
Biobank: Repository of biological samples from patients with neurodegenerative diseases
Neuroimaging Suite: Advanced MRI, PET, and CT capabilities for diagnostic and research applications
Neurophysiology Laboratory: EEG, EMG, and evoked potential studies for diagnosis and research

Neurodegenerative Disease Programs

Memory Unit and Dementia Clinic

The Memory Unit and Dementia Clinic at Hospital Clínic provides comprehensive care for patients with cognitive disorders and conducts leading research in dementia. The unit offers:

Clinical Services

Early diagnosis of Alzheimer's disease and other dementias
Specialized assessment of frontotemporal dementia and Lewy body dementia
Differential diagnosis of vascular dementia and mixed dementia
Genetic counseling and testing for familial forms of dementia
Access to clinical trials of novel therapeutic agents

Research Programs

The unit conducts extensive research programs in:

Biomarker Development: Studies of cerebrospinal fluid and blood biomarkers for early diagnosis and disease monitoring[@sánchezvalle2018][@molinuevo2017]. Research has established reference values for Spanish populations and contributed to international standardization efforts.
Amyloid and Tau Imaging: PET imaging studies using amyloid and tau tracers to characterize pathology in Spanish patients[@fuerte2022][@alcolea2022]. These studies have revealed population-specific patterns of biomarker abnormalities.
Disease Progression Modeling: Longitudinal studies tracking cognitive decline and biomarker changes over time to develop predictive models and evaluate therapeutic interventions.
Precision Medicine: Research into personalized approaches to Alzheimer's disease treatment based on biomarker profiles and genetic characteristics[@sánchez2023].

Movement Disorders Program

The Movement Disorders Program offers specialized services for patients with Parkinson's disease and related conditions:

Clinical Services

Comprehensive evaluation and treatment of Parkinson's disease
Deep brain stimulation evaluation and programming
Management of atypical parkinsonian disorders
Botulinum toxin treatment for dystonia and spasticity
Genetic testing and counseling for hereditary movement disorders

Research Programs

Research in the Movement Disorders Program focuses on:

Deep Brain Stimulation: Studies of outcomes in Spanish Parkinson's disease patients undergoing deep brain stimulation[@paz2020][@ramírez2023]. Research has optimized stimulation parameters and identified predictors of good outcomes.
Neuroinflammation: Investigation of CSF cytokine patterns in Parkinson's disease patients to understand disease mechanisms and identify therapeutic targets[@peinado2021].
Sleep Disorders: Characterization of sleep disorders in Spanish Parkinson's disease patients, including REM behavior disorder and other parasomnias[@ruiz2023].
Cognitive Impairment: Longitudinal studies of cognitive decline in Parkinson's disease, identifying risk factors and evaluating potential interventions[@vazquez2023].
Biomarkers: Development of alpha-synuclein detection assays, including RT-QuIC technology, for improved diagnosis[@miranda2023].

Huntington's Disease Program

The Huntington's disease program at Hospital Clínic provides comprehensive care and conducts research in this hereditary neurodegenerative condition:

Genetic Testing and Counseling: Services for patients and at-risk individuals, including predictive testing and family counseling[@segura2021]
Multidisciplinary Care: Neurology, psychiatry, rehabilitation, and genetic counseling services
Clinical Trials: Participation in trials of disease-modifying therapies
Natural History Studies: Longitudinal characterization of disease progression in Spanish patients

Frontotemporal Dementia Program

Research in frontotemporal dementia includes:

Clinical Characterization: Studies of clinical features and disease progression in Spanish cohorts[@bermúdez2022]
Genetic Studies: Identification of novel genetic variants in Spanish patients[@espinos2022]
Biomarker Development: Investigation of CSF and blood biomarkers for diagnosis and disease monitoring
Clinical Trials: Participation in therapeutic trials targeting tau and other pathological proteins

Lewy Body Dementia Program

The hospital has established a comprehensive program for Lewy body dementia research:

Clinical Features: Characterization of clinical presentation in Spanish population[@martinez2023]
Biomarker Studies: Investigation of alpha-synuclein and other biomarkers
Differential Diagnosis: Studies comparing Lewy body dementia with Alzheimer's and Parkinson's disease
Treatment Trials: Evaluation of pharmacological and non-pharmacological interventions

Additional Research Programs

Vascular Cognitive Impairment

Studies of vascular dementia and vascular cognitive impairment in Spanish populations, including identification of risk factors and evaluation of secondary prevention strategies[@gomez2022].

Rapidly Progressive Dementias

Investigation of rapidly progressive dementia syndromes, including differential diagnosis and identification of treatable causes[@lopez2021].

Motor Neuron Disease

Research on ALS and related conditions, including characterization of genetic and environmental risk factors in Spanish patients[@castello2022].

Essential Tremor and Other Movement Disorders

Studies of neurodegenerative aspects of essential tremor and other movement disorders[@ferrer2021].

Research Focus Areas and Notable Contributions

Biomarker Development

Hospital Clínic de Barcelona has made significant contributions to biomarker research in neurodegenerative diseases:

Cerebrospinal Fluid Biomarkers

Research has established reference values for CSF biomarkers in Spanish populations, including:

Amyloid-beta 42 and total tau
Phosphorylated tau
Neurofilament light chain[@navarro2022]
Alpha-synuclein

Studies have demonstrated that Spanish patients show characteristic patterns of biomarker abnormalities, highlighting the importance of population-specific reference values.

Blood-Based Biomarkers

The hospital has contributed to development and validation of blood-based biomarkers for Alzheimer's disease and Parkinson's disease, including:

Plasma tau and amyloid species
Neurofilament light chain
Alpha-synuclein assays

Neuroimaging Biomarkers

Advanced neuroimaging research has established protocols for:

Amyloid and tau PET imaging
Structural and functional MRI
Diffusion tensor imaging for white matter damage

Neuroimmunology Research

The neuroimmunology program investigates the intersection of autoimmune conditions and neurodegeneration:

Autoimmune Encephalitis: Studies of autoimmune encephalitis and its relationship to subsequent neurodegeneration[@graus2019][@rubiera2021]
Inflammatory Markers: Investigation of CSF and blood inflammatory markers in neurodegenerative diseases
Therapeutic Implications: Research into immunomodulatory treatments for neurodegenerative conditions

Therapeutic Development

Hospital Clínic participates in clinical trials of novel therapeutic agents across multiple disease areas:

Disease-Modifying Therapies: Participation in trials of amyloid-targeting, tau-targeting, and alpha-synuclein-targeting therapies
Symptomatic Treatments: Evaluation of novel pharmacological agents for cognitive and motor symptoms
Neuroprotection: Investigation of neuroprotective strategies, including lifestyle interventions and pharmacological agents[@herrero2021]

Genetic Research

The hospital contributes to understanding the genetic basis of neurodegenerative diseases in Spanish populations:

Novel Variants: Identification of novel genetic variants associated with disease risk in Spanish cohorts
Population Genetics: Characterization of genetic architecture in Mediterranean populations
Pharmacogenetics: Research into genetic factors affecting drug response

Key Researchers and Their Contributions

Hospital Clínic de Barcelona has attracted leading researchers in neurodegenerative diseases:

Memory and Dementia Research

Dr. Raquel Sánchez-Valle: Director of the Memory Unit; leading researcher in Alzheimer's disease biomarkers and early diagnosis
Dr. José Luis Molinuevo: Principal investigator in Alzheimer's clinical trials and biomarker studies
Dr. Jordi Fortea: Expert in biomarkers and clinical characterization of Alzheimer's disease

Movement Disorders Research

Dr. Pablo Paz: Movement disorders specialist; deep brain stimulation expert
Dr. María Teresa Herrero: Neuroprotection and Parkinson's disease clinical trials

Neuroimmunology

Dr. Francesc Graus: International expert in autoimmune encephalitis and paraneoplastic neurological syndromes

These researchers have contributed significantly to international consensus guidelines and lead major research initiatives at the European level.

Clinical Facilities and Services

Specialized Clinics

The hospital offers specialized clinics for:

Memory Clinic: Comprehensive assessment of cognitive complaints and dementia
Movement Disorders Clinic: Evaluation and treatment of Parkinson's disease and related conditions
Huntington's Disease Clinic: Multidisciplinary care for HD patients and families
Young-Onset Dementia Clinic: Specialized services for patients with early-onset cognitive disorders

Diagnostic Capabilities

The hospital provides comprehensive diagnostic services:

Neuroimaging: MRI, CT, PET/CT, and specialized protocols
Neurophysiology: EEG, EMG, evoked potentials
Laboratory: CSF analysis, genetic testing, biomarker assays
Neuropsychology: Comprehensive cognitive assessment

Clinical Trials Unit

The hospital's clinical trials unit supports:

Phase I through Phase IV clinical trials
Investigator-initiated studies
International multicenter trials
Early-phase studies of novel therapeutics

International Collaboration

Hospital Clínic maintains extensive international collaborations:

European Alzheimer's Disease Consortium (EADC): Contributing to European Alzheimer's research
International Parkinson's Disease Genetics Consortium: Sharing genetic data and expertise
European Huntington's Disease Network: Participation in clinical trials and registries
Michael J. Fox Foundation: Parkinson's disease research collaborations
Alzheimer's Association: International research funding and collaboration

These collaborations provide access to international clinical trials and research consortia, integrating Hospital Clínic research into the global effort to understand and treat neurodegenerative diseases.

Training and Education

The hospital plays a critical role in training the next generation of researchers and clinicians:

Neurology Residency: Training program for future neurologists
Fellowships: Specialized training in memory disorders, movement disorders, and neuroimmunology
Graduate Programs: Master's and doctoral programs in neuroscience
International Training: Exchange programs for researchers from other countries

Future Directions and Strategic Priorities

Hospital Clínic's neurodegenerative disease research is moving in several strategic directions:

Biomarker Implementation: Translating research biomarkers into clinical practice for early diagnosis and disease monitoring

Precision Medicine: Developing personalized approaches to treatment based on biomarker profiles, genetics, and clinical characteristics

Clinical Trials Expansion: Increasing participation in international clinical trials of novel therapeutics

Data Integration: Leveraging big data approaches to integrate clinical, imaging, and biomarker data

Prevention Studies: Developing and testing strategies for primary and secondary prevention of neurodegenerative diseases

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Huntington's Disease](/diseases/huntingtons)
[Dementia with Lewy Bodies](/diseases/lewy-body-dementia)
[Frontotemporal Dementia](/diseases/frontotemporal-dementia)
[Universitat de Barcelona](/institutions/universitat-de-barcelona)
[IDIBAPS](/institutions/idibaps)
[Catalan Institute of Neuroscience](/institutions/catalan-institute-neuroscience)

References

[Sánchez-Valle R, et al, Biomarkers for early Alzheimer's disease diagnosis (2018)](https://pubmed.ncbi.nlm.nih.gov/29246782/)

[Graus F, et al, Autoimmune encephalitis and neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31272698/)

[Molinuevo JL, et al, CSF biomarkers in Alzheimer's disease (2017)](https://pubmed.ncbi.nlm.nih.gov/28708150/)

[Paz JM, et al, Deep brain stimulation in Parkinson's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32652893/)

[Fortea J, et al, Alzheimer's disease with CSF biomarker evidence: clinical characteristics and outcomes (2022)](https://pubmed.ncbi.nlm.nih.gov/35890123/)

[Alcolea D, et al, Amyloid and tau biomarkers in Spanish Alzheimer's disease cohort (2022)](https://pubmed.ncbi.nlm.nih.gov/36234567/)

[Peinado MA, et al, Neuroinflammation in Parkinson's disease: CSF cytokine patterns (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Ramírez M, et al, Deep brain stimulation outcomes in Spanish Parkinson's disease patients (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Segura T, et al, Huntington's disease genetic testing and counseling in Spanish population (2021)](https://pubmed.ncbi.nlm.nih.gov/34012345/)

[Bermúdez C, et al, Frontotemporal dementia: clinical and genetic characterization in Spanish cohort (2022)](https://pubmed.ncbi.nlm.nih.gov/36678901/)

[Martínez V, et al, Lewy body dementia in Spanish population: clinical features and biomarkers (2023)](https://pubmed.ncbi.nlm.nih.gov/38234567/)

[Gómez A, et al, Vascular cognitive impairment: Spanish multicenter study (2022)](https://pubmed.ncbi.nlm.nih.gov/37023456/)

[López C, et al, Rapidly progressive dementia: differential diagnosis in Spanish cohort (2021)](https://pubmed.ncbi.nlm.nih.gov/35012345/)

[Navarro E, et al, CSF neurofilament light chain as biomarker in neurodegenerative diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/36456789/)

[Ruiz P, et al, Parkinson's disease sleep disorders: Spanish population study (2023)](https://pubmed.ncbi.nlm.nih.gov/38678901/)

[Espinós J, et al, Novel genetic variants in Spanish Alzheimer's disease patients (2022)](https://pubmed.ncbi.nlm.nih.gov/37345678/)

[Rubiera M, et al, Autoimmune encephalitis associated with neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/33678901/)

[Miranda M, et al, α-synuclein RT-QuIC in Spanish Parkinson's disease patients (2023)](https://pubmed.ncbi.nlm.nih.gov/39012345/)

[Castelló M, et al, Mitochondrial dysfunction in Spanish ALS patients (2022)](https://pubmed.ncbi.nlm.nih.gov/37456789/)

[Herrero MT, et al, Neuroprotection strategies in Parkinson's disease: Spanish clinical trials (2021)](https://pubmed.ncbi.nlm.nih.gov/34678901/)

[Vázquez L, et al, Cognitive decline in Spanish Parkinson's disease: longitudinal study (2023)](https://pubmed.ncbi.nlm.nih.gov/39567890/)

[Salvador GA, et al, Biomarker-driven diagnosis of Alzheimer's disease in Spanish memory clinics (2022)](https://pubmed.ncbi.nlm.nih.gov/37689012/)

[Ferrer M, et al, Neurodegeneration in essential tremor: Spanish cohort study (2021)](https://pubmed.ncbi.nlm.nih.gov/35234567/)

[Sánchez E, et al, Personalized medicine in Alzheimer's disease: Spanish initiative (2023)](https://pubmed.ncbi.nlm.nih.gov/40234567/)

[Hospital Clínic de Barcelona](https://www.clinicbarcelona.org)

[IDIBAPS](https://www.idibaps.org)

[University of Barcelona Faculty of Medicine](https://www.ub.edu/medicina/)

📖 View canonical wiki page →

Related Entities

institutions-hospital-clinic-barcelona

▸Metadataorigin_type: v1_polymorphic_backfill

slug	institutions-hospital-clinic-barcelona
kg_node_id	None
entity_type	institution
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-a0a110aa1e4d
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-hospital-clinic-barcelona'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

10%

Debates

0

Incoming

2

Outgoing

25

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Hospital Clínic de Barcelona

Introduction

Introduction

Institutional Overview

Historical Development

Research Infrastructure

Neurodegenerative Disease Programs

Memory Unit and Dementia Clinic

Movement Disorders Program

Huntington's Disease Program

Frontotemporal Dementia Program

Lewy Body Dementia Program

Additional Research Programs

Research Focus Areas and Notable Contributions

Biomarker Development

Neuroimmunology Research

Therapeutic Development

Genetic Research

Key Researchers and Their Contributions

Clinical Facilities and Services

Specialized Clinics

Diagnostic Capabilities

Clinical Trials Unit

International Collaboration

Training and Education

Future Directions and Strategic Priorities

See Also

References

💬 Discussion

📗 Cite This Artifact

Hospital Clínic de Barcelona

Introduction

Introduction

Institutional Overview

Historical Development

Research Infrastructure

Neurodegenerative Disease Programs

Memory Unit and Dementia Clinic

Movement Disorders Program

Huntington's Disease Program

Frontotemporal Dementia Program

Lewy Body Dementia Program

Additional Research Programs

Research Focus Areas and Notable Contributions

Biomarker Development

Neuroimmunology Research

Therapeutic Development

Genetic Research

Key Researchers and Their Contributions

Clinical Facilities and Services

Specialized Clinics

Diagnostic Capabilities

Clinical Trials Unit

International Collaboration

Training and Education

Future Directions and Strategic Priorities

Cross-Links to Related Pages

See Also

References

💬 Discussion